Polyunsaturated fatty acids
Polyunsaturated fatty acids has been studied in 136 papers since 1989: 5 trials and 73 observational studies in people, 6 in animals, 1 in cells, 51 reviews; 35 in the past year. The newest paper, Nov 10, 2026: “Effects of Polyunsaturated Fatty Acids, Specifically Omega-3, on Diabetic Retinopathy—A Systematic Integrative Review”.
136 papers study it61 findingsUpdated
Research on it is growing 30% faster than aging research as a whole: 41 papers in the latest year counted
3 new papers in 30 daysSee all 135 papers on polyunsaturated fatty acids
At a glance
Polyunsaturated fatty acids are linked with lower PhenoAge across independent human studies, but a human study links them with shorter lifespan in men. A study in female mice finds no clear lifespan effect from n-3 or n-6 supplementation. Independent human studies link them with higher breast cancer risk in women; some papers declare company ties.
61 findings in 51 papers from 2010 to 2026, 8 of them since May 2026
Independent labs found the same change in people. 37 independent labs in 15 countries; 1 trial, none about aging.
“PFA alone amounted to €111,720 per improved Z score point.”
6 of its findings point the other way.
- 37 independent labs in 15 countries
- 6 findings against
- 1 trial, none about aging
- Funders: National Institutes of Health and others
- 2 of 52 findings with company ties
- Human trial5
- Humans72
- Animals4
- Model organisms2
- Cells1
Studies in people
1 study gave polyunsaturated fatty acids to people and measured what changed.
| What changed | Design | People | Source |
|---|---|---|---|
down: Decreases intrahepatic lipid content-0.03% (95% CI -0.05, -0.01) | Randomized trial12 months | 248 peopleBoth50-80 yOlder adults; Midlife adults; independent of BMI changes | Clinical nutrition (Edinburgh, Scotland), Nov 14, 2024 |
What did studies of polyunsaturated fatty acids find?
17Studies of polyunsaturated fatty acids measured 17 outcomes; the most studied are lifespan (3 studies) and cognitive function (2).
Lifespan
no changein humans1downin humans1no changein mice1is required forin worms1
3 studies
Lifespan
no changein humans1downin humans1no changein mice1is required forin worms1
Polyunsaturated fatty acids were not clearly linked with lifespan in humans (0.20, 95% CI -0.32 to 0.70).
“lifespan in men (-0.76 years, 95% CI -1.34 to -0.17) but not women (0.20, 95% CI -0.32 to 0.70).”
Humansfemales
International journal of epidemiology
Polyunsaturated fatty acids are linked with shorter lifespan in humans (-0.76 years, 95% CI -1.34 to -0.17).
“PUFAs were associated with IHD [odds ratio 1.23, 95% confidence interval (CI) 1.05 to 1.44] and lifespan in men (-0.76 years, 95% CI -1.34 to -0.17)”
Humansmales
International journal of epidemiology
Polyunsaturated fatty acids are required for lifespan in worms (longevity-promoting effect of lysosomal lipolysis).
“This cell-non-autonomous regulation requires the secretion from the fat storage tissue of a lipid chaperone protein LBP-3 and polyunsaturated fatty acids (PUFAs)”
Model organismslongevity-promoting effect of lysosomal lipolysis
Lysosome Lipid Signaling from the Periphery to Neurons Regulates Longevity
bioRxiv (Cold Spring Harbor Laboratory)Preprint
Polyunsaturated fatty acids showed no clear effect on lifespan in mice (supplementation of n-3 or n-6 PUFAs).
“while membrane phospholipid composition clearly differed between feeding groups, life span was not directly affected.”
Animalssupplementation of n-3 or n-6 PUFAsheart and liverfemales
Journal of comparative physiology. B, Biochemical, systemic, and environmental physiology
Cognitive function
downin humans1upin reviews1
2 studies
Cognitive function
downin humans1upin reviews1
Polyunsaturated fatty acids are linked with worse cognitive function in humans (β = -13.97, p = 0.04).
“Males had lower total RBANS scores with a higher PUFA intake (β = -13.97, p = 0.04)”
Humansmalesn = 321
Nutrients
Polyunsaturated fatty acids improve cognitive function (aging-related).
“marine-derived polyunsaturated fatty acids (PUFAs) and bioactive peptides emerging as promising candidates for enhancing brain health and cognitive function.”
Reviewaging-related
Frontiers in nutrition
Estimated bone mineral density
downin humans1upin humans1OR 0.947–1.03
1 study
Estimated bone mineral density
downin humans1upin humans1OR 0.947–1.03
Polyunsaturated fatty acids are linked with lower estimated bone mineral density in humans (two-sample Mendelian randomization, inverse variance weighting) (OR 0.947 (95% CI 0.924–0.970), P < 0.001; survived Bonferroni correction).
“n-6 to n-3 (OR = 0.947, 95% CI: 0.924, 0.970, P < 0.001) were negatively correlated with eBMD”
Humanstwo-sample Mendelian randomization, inverse variance weightingn-6 to n-3 ratio
Causal effect of polyunsaturated fatty acids on bone mineral density and fracture
Frontiers in nutrition
Polyunsaturated fatty acids are linked with higher estimated bone mineral density in humans (two-sample Mendelian randomization, inverse variance weighting) (OR 1.030 (95% CI 1.013–1.047), P = 0.001; survived Bonferroni correction).
“n-3 PUFAs (OR = 1.030, 95% CI: 1.013, 1.047, P = 0.001) and n-6 PUFAs (OR = 1.053, 95% CI: 1.034, 1.072, P < 0.001) were positively correlated with eBMD”
Humanstwo-sample Mendelian randomization, inverse variance weightingn-3 PUFAs
Causal effect of polyunsaturated fatty acids on bone mineral density and fracture
Frontiers in nutrition
White matter hyperintensity volume
downin silico1
1 study
White matter hyperintensity volume
downin silico1
Polyunsaturated fatty acids decrease white matter hyperintensity volume in silico (β = -0.070, 95% CI: -0.126 to -0.015).
“Higher polyunsaturated fatty acid (PUFA) levels demonstrated a protective effect against WMH volume (β = -0.070, 95% CI: -0.126 to -0.015; se = 0.028; p = 0.013, FDR-adjusted p = 0.033).”
In silico
Causal Effect of Dietary Patterns on Cerebral Small Vessel Disease: A Mendelian Randomization Study
Food science & nutrition
Sarcopenia
no changein humans1
1 study
Sarcopenia
no changein humans1
Polyunsaturated fatty acids were not clearly linked with sarcopenia in humans.
“No significant associations were found between PUFAs-related variables and sarcopenia.”
Humans
The journal of nutrition, health & aging
Intrahepatic lipid content
downin humans1
1 study
Intrahepatic lipid content
downin humans1
Polyunsaturated fatty acids decrease intrahepatic lipid content in humans (independent of BMI changes) (-0.03% (95% CI -0.05, -0.01)).
“Increase in PUFA intake was also directly associated with IHL improvement independently of BMI changes (estimate for linear relative change -0.03 % (95%CI -0.05, -0.01)).”
Human trialindependent of BMI changes12 months
Clinical nutrition (Edinburgh, Scotland)
Cognitive decline
downin humans1
1 study
Cognitive decline
downin humans1
Polyunsaturated fatty acids decrease cognitive decline in humans with normal cognition, mild cognitive impairment (MCI), or Alzheimer's disease (AD).
“supplementation with vitamin D, probiotics, and PUFAs would most likely reduce cognitive decline, dementia, or AD compared with vitamins A, B, C, and E, which were seen to be relatively ineffective.”
Reviewwith normal cognition, mild cognitive impairment (MCI), or Alzheimer's disease (AD)
Nutrients
Lung cancer
no changein humans1
1 study
Lung cancer
no changein humans1
Polyunsaturated fatty acids were not clearly linked with lung cancer in humans.
“No significant association was found between consumption of monounsaturated or polyunsaturated fatty acids and incident lung cancer and its subtypes.”
Humans
The journal of nutrition, health & aging
Frailty
upin silico1OR 1.033
1 study
Frailty
upin silico1OR 1.033
Polyunsaturated fatty acids increase frailty in silico (OR: 1.033, 95% CI: 1.009-1.057).
“PUFA was also associated with a higher FI (OR: 1.033, 95% CI: 1.009-1.057).”
In silico
Relationship between fatty acid intake and aging: a Mendelian randomization study
Aging
Telomere length
upin silico1OR 1.167
1 study
Telomere length
upin silico1OR 1.167
Polyunsaturated fatty acids increase telomere length in silico (OR: 1.1670, 95% CI = 1.0497-1.2973).
“PUFA OR: 1.1670, 95% CI = 1.0497-1.2973”
In silico
Relationship between fatty acid intake and aging: a Mendelian randomization study
Aging
All 17Fewer
What is polyunsaturated fatty acids linked with?
32Studies link polyunsaturated fatty acids with 32 measures, among them mortality, cataract and cardiovascular disease.
Mortality
downin humans3upin humans1HR 0.81–1.3
3 studies
Mortality
downin humans3upin humans1HR 0.81–1.3
Polyunsaturated fatty acids are linked with a lower risk of mortality in humans (highest vs lowest tertile) (HR = 0.86, p for trend < 0.01).
“Conversely, the highest PUFA/TFAT tertile demonstrated a protective association (HR = 0.86, p for trend < 0.01).”
Humanshighest vs lowest tertilen = 21,823
Lipids in health and disease
Polyunsaturated fatty acids are associated with mortality in humans (HR 0.83, 95% CI 0.78–0.89 per 5% increment in energy intake).
“The HRs of all-cause mortality (95% CI) were 0.83 (0.78, 0.89) and 0.91 (0.87, 0.94)”
Humans5% increment in energy intakemale and femalesn = 65,179
The American journal of clinical nutrition
Polyunsaturated fatty acids are linked with a higher risk of mortality in humans (HR 1.30 [1.13-1.50]).
“However, the inverted L-shaped non-linear trend in all-cause mortality was found with increasing intake at breakfast of TUFA (HR: 1.35 [1.17-1.57], Q3 vs. Q1), PUFA (HR: 1.30 [1.13-1.50])”
Humansat breakfast
Nutrients
Polyunsaturated fatty acids are linked with a lower risk of mortality in humans (HR 0.81 [0.73-0.91]).
“All-cause mortality decreased with increasing intakes at dinner of TUFA (HR: 0.87 [0.77-0.98]), PUFA (HR: 0.81 [0.73-0.91]), and MUFA (HR: 0.88 [0.77-0.99]).”
Humansat dinner
Nutrients
Cataract
downin humans1upin humans1downin silico1OR 0.93
3 studies
Cataract
downin humans1upin humans1downin silico1OR 0.93
Polyunsaturated fatty acids are associated with cataract in humans.
“A lower intake of polyunsaturated fatty acids and vitamin A, and a higher intake of vitamin B2 in the female group were associated with a higher incidence of cataracts.”
Humansfemales
The Relationship between Nutrient Intake and Cataracts in the Older Adult Population of Korea
Nutrients
Polyunsaturated fatty acids are linked with a higher risk of cataract in humans (ORhigh_mid = 1.524).
“A higher intake of polyunsaturated fatty acids (ORhigh_mid =1.524) and vitamin B1 (ORhigh_mid =0.605) in the men’s group and the lower intake of sugar (ORlow_mid=1.321)”
Humansmales
Preprint
Polyunsaturated fatty acids lower the risk of cataract in silico (OR = 0.93, 95% CI, 0.89-0.97).
“and polyunsaturated fatty acids (PUFAs) (OR = 0.93, 95% CI, 0.89-0.97) with ARC.”
In silico
Metabolomic signatures and causal effects of circulating metabolites on age-related cataract
The journals of gerontology. Series A, Biological sciences and medical sciences
Cardiovascular disease
downin humans2OR 0.52
2 studies
Cardiovascular disease
downin humans2OR 0.52
Polyunsaturated fatty acids are linked with a lower risk of cardiovascular disease in individuals with loneliness and anxiety/depression.
“higher intakes of alpha‐linolenic acid (ALA), stearidonic acid (SDA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA) were negatively associated with total CVD risk in individuals with loneliness and anxiety/depression.”
Humansin individuals with loneliness and anxiety/depression
Med Research
Polyunsaturated fatty acids lower the risk of cardiovascular disease in humans (patients with ESRD receiving dialysis) (Peto OR 0.52, 95% CI 0.32 to 0.85, P = 0.009).
“the PUFA group demonstrated decreased cardiovascular events (Peto odds ratio = 0.52, 95% confidence interval [CI] = 0.32 to 0.85, P = 0.009)”
Reviewpatients with ESRD receiving dialysis
Food & function
Breast cancer
upin humans2HR 1.1
2 studies
Breast cancer
upin humans2HR 1.1
Polyunsaturated fatty acids are linked with a higher risk of breast cancer in humans (HR 1.10, 95% CI 1.02-1.17).
“1.02 (0.96, 1.08) and 1.10 (1.02, 1.17) for breast cancer”
Humansfemalesn = 82,121
Diet composition linked to disease risk after menopause
The American journal of clinical nutrition
Polyunsaturated fatty acids are linked with a higher risk of breast cancer in humans (Q4 vs. Q1 in postmenopausal women) (OR = 2.12, 95 % CI = 1.05-4.27).
“A positive significant association was observed between animal fat (Q4 vs. Q1, OR = 1.89, 95 % CI = 0.93-3.81), saturated fatty acid (SFA) (Q4 vs. Q1, OR = 1.70, 95 % CI = 0.88-3.30), monounsaturated fatty acid (MUFA) (Q4 vs. Q1 OR = 1.85, 95 % CI = 0.95-3.61) and PUFA intake (Q4 vs. Q1, OR = 2.12, 95 % CI = 1.05-4.27) with BC risk in postmenopausal women.”
HumansQ4 vs. Q1 in postmenopausal womenfemales
Lipids in health and disease
Cardiovascular outcomes
downin humans1
1 study
Cardiovascular outcomes
downin humans1
Polyunsaturated fatty acids are associated with cardiovascular outcomes in humans.
“Replacing SFA with PUFA appears to be associated with favorable cardiovascular outcomes in observational and well-conducted short-duration clinical research studies.”
ReviewReplacing saturated fatty acids in observational and well-conducted short-duration clinical research studies
Advances in nutrition (Bethesda, Md.)
Lung cancer
downin humans1OR 0.48
1 study
Lung cancer
downin humans1OR 0.48
Polyunsaturated fatty acids are linked with a lower risk of lung cancer in humans (highest versus lowest intake tertiles) (OR 0.48, 95% CI 0.30-0.79).
“total PUFAs: OR = 0.48, 95% CI: 0.30-0.79”
Humanshighest versus lowest intake tertiles
PloS one
Heart failure
downin humans1HR 0.87
1 study
Heart failure
downin humans1HR 0.87
Polyunsaturated fatty acids are linked with a lower risk of heart failure in humans (Model 2) (HR 0.87, 95% CI 0.77, 0.98).
“In Model 2, higher polyunsaturated fatty acid (PUFA) intake was associated with lower HF risk (HR 0.87, 95% CI 0.77, 0.98).”
HumansModel 212 yearsn = 124,777
Clinical nutrition ESPEN
Age at natural menopause
upin humans1
1 study
Age at natural menopause
upin humans1
Polyunsaturated fatty acids are associated with age at natural menopause in humans.
“diets rich in fiber and polyunsaturated fats appear to be correlated with later menopause”
Reviewfemales
Impact of Nutrition on Age at Natural Menopause
Nursing Edição Brasileira
Type 2 diabetes
upin humans1HR 1.07
1 study
Type 2 diabetes
upin humans1HR 1.07
Polyunsaturated fatty acids are linked with a higher risk of type 2 diabetes in humans (HR 1.07, 95% CI 1.03-1.12).
“and 1.07 (1.03, 1.12) for T2D.”
Humansfemalesn = 82,121
Diet composition linked to disease risk after menopause
The American journal of clinical nutrition
Gastric cancer
downin humans1RR 0.77
1 study
Gastric cancer
downin humans1RR 0.77
Polyunsaturated fatty acids lower the risk of gastric cancer in humans (RR 0.77, 95% CI 0.65–0.92).
“PUFA intake was inversely associated with gastric cancer (RR: 0.77; 95% CI: 0.65, 0.92).”
Review
The American journal of clinical nutrition
Cost per improved cognitive Z-score point
upin humans1
1 study
Cost per improved cognitive Z-score point
upin humans1
Polyunsaturated fatty acids are associated with cost per improved cognitive Z-score point in humans (compared with placebo) (€111,720 per improved cognitive Z-score point).
“PFA alone amounted to €111,720 per improved Z score point.”
Human trialcompared with placebo3 yearsn = 1,525
The journal of prevention of Alzheimer's disease
25-hydroxyvitamin D
downin humans1
1 study
25-hydroxyvitamin D
downin humans1
Polyunsaturated fatty acids are associated with 25-hydroxyvitamin D in humans (β = -0.93; P = 0.038).
“negatively associated with PUFA, (β = -0.93; P = 0.038)”
Human trialplasma700 IU/d vitamin D3 and 500 mg/d calcium2 yrn = 152
The Journal of clinical endocrinology and metabolism
All 32Fewer
Funding
5 grants since 2016National Eye Institute$1.6MNational Heart, Lung, and Blood Institute$858KJapan Society for the Promotion of Science¥13.7M
Elucidating the Role of Very-long-chain Polyunsaturated Fatty Acids in Retinal Health and Disease
National Eye InstituteUniversity of Utah$391K2023–2027
Role of polyunsaturated fatty acids in pulmonary fibrosis
National Heart, Lung, and Blood InstituteUniversity of Virginia$172K2021–2026
Japan Society for the Promotion of ScienceNagoya University of Arts and Sciences¥10.7M2020–2023
National Health and Medical Research CouncilMonash UniversityA$1.1M2017–2021
Japan Society for the Promotion of ScienceKyoto Medical Center¥3M2016–2018
How this record changed
Summary written from the findings.